Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Loading…
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Loading…